Drugs / RTS,S/AS02D
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00197028 | Aug 2005 → Dec 2007 | Plasmodium falciparum malaria | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RTS,S/AS02D | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00197028 ↗ |
| Known as | GSK 257049 | “the candidate malaria vaccine, GSK 257049 vaccine (0.5 ml dose)” NCT00197028 ↗ |
| Modality | Vaccine | “candidate malaria vaccine” NCT00197028 ↗ |